Product Information
REXULTI 0.5 MG TABLET is a brand product labeled by Otsuka America Pharmaceutical Inc., priced at $49.5054 per EA under NDC 59148003613. Its NADAC has been published 553 times since Jan 20, 2016.
FDA first approved this application on Jul 10, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/1
Manufacturer
Otsuka America Pharmaceutical Inc.NDC
59148003613
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BREXPIPRAZOLEApproval Type
New Drug (NDA)
FDA Application
NDA205422FDA Approved
7/10/2015
TE Code
AB
On Market Since
7/10/2015
Pharmacological Classes
Price Statistics
The NADAC for REXULTI 0.5 MG TABLET has been published 553 times since Jan 20, 2016, and over the history we have for it it has risen 80.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $49.5054 per EA |
|---|---|
| All-time high | $49.6522 (May 13, 2026) |
| All-time low | $27.5082 (Jan 20, 2016) |
| 52-week high | $49.6522 |
| 52-week low | $48.3502 |
| Median price | $39.8336 |
| Average price | $39.8780 |
| Largest weekly change | +9.9% (Apr 11, 2018) |
| Weeks tracked | 553 |
| Tracking since | Jan 20, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the brexpiprazole market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of REXULTI 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for REXULTI 0.5 MG TABLET, manufactured by Otsuka America Pharmaceutical Inc., is $49.5054 per EA (NDC 59148003613), effective Aug 19, 2026.
How has the price of REXULTI 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for REXULTI 0.5 MG TABLET has risen 80.0%. It has been tracked across 553 weekly CMS publications since Jan 20, 2016.
What are the highest and lowest recorded NADAC prices for REXULTI 0.5 MG TABLET?
Since Jan 20, 2016, the NADAC for REXULTI 0.5 MG TABLET has ranged from a low of $27.5082 (Jan 20, 2016) to a high of $49.6522 (May 13, 2026), with a median of $39.8336 per EA.
Are there cheaper alternatives to REXULTI 0.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of REXULTI 0.5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures REXULTI 0.5 MG TABLET?
REXULTI 0.5 MG TABLET (NDC 59148003613) is labeled by Otsuka America Pharmaceutical Inc., and CMS classifies it as a brand product.